Intrinsic Value of S&P & Nasdaq Contact Us

SeqLL Inc. SQL NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
33/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

SeqLL Inc. (SQL) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 32/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
33/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
30/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SQL

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.55
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.68
Book Value / Share$0.00
Revenue / Share$12.03
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-11.79 $939.68K $-1.43M -152.6%
2017 $-5.84 $1.34M $-1.71M -127.5%
2018 $-23.75 $779.07K $-2.89M -370.7%
2019 $-21.84 $160.48K $-2.66M -1654.9%
2020 $-12.53 $50.59K $-1.52M -3012.8%
2021 $-21.65 $48.02K $-3.91M -8134.1%
2022 $-14.11 $1.18K $-4.19M -356203.7%
2024 $-3.68 $442.61M $-135.48M -30.6%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message